Page last updated: 2024-09-03

gefitinib and Cancer of Spleen

gefitinib has been researched along with Cancer of Spleen in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bae, JH; Baek, MC; Cho, SY; Cho, Y; Choi, YJ; Jeong, SB; Jun, DW; Kang, KW; Kang, S; Kim, JK; Kim, JW; Kim, KM; Kim, W; Kim, Y; Lee, H; Lee, SH; Lim, SC; Park, M	1

Other Studies

1 other study(ies) available for gefitinib and Cancer of Spleen

Article	Year
Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance. Cancer research, 2021, 07-01, Volume: 81, Issue:13 Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Extracellular Vesicles; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Receptor Protein-Tyrosine Kinases; Splenic Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2021

Article

Year

Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance.

Cancer research, 2021, 07-01, Volume: 81, Issue:13

Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Extracellular Vesicles; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Receptor Protein-Tyrosine Kinases; Splenic Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2021